Roundup Lawsuit: Non-Hodgkin Lymphoma Claims

Roundup weed killer is linked to non-Hodgkin lymphoma. The $7.25B proposed settlement, the 2026 Supreme Court ruling, who may qualify, and how to check eligibility.

Last updated July 19, 2026 By LawfareClaims.org

Roundup is the best-selling weed killer in the United States — and the subject of one of the largest mass tort litigations in American history. Tens of thousands of people who used Roundup allege the herbicide caused their non-Hodgkin lymphoma. Here is where the litigation stands and how to check if you may qualify.

What Is Roundup and Why Is It Being Sued Over?

Roundup is a glyphosate-based herbicide originally developed by Monsanto (acquired by Bayer AG in 2018) and sold since the 1970s to farmers, landscapers, and home gardeners. It remains one of the most widely used weed killers in the world.

In 2015, the International Agency for Research on Cancer (IARC) — the cancer-research arm of the World Health Organization — classified glyphosate as "probably carcinogenic to humans" (Group 2A), citing evidence linking it to non-Hodgkin lymphoma (NHL). That classification became the scientific basis for tens of thousands of lawsuits alleging Monsanto/Bayer knew of the cancer risk and failed to warn users.

Bayer disputes that Roundup causes cancer and maintains that regulators including the U.S. EPA have repeatedly found glyphosate safe for its labeled uses. The litigation turns on that scientific and regulatory dispute.

Who May Qualify for a Roundup Lawsuit?

You may have grounds for a claim if you were regularly exposed to Roundup — through occupational spraying, landscaping, farming, or repeated home and garden use — and were later diagnosed with non-Hodgkin lymphoma or a related lymphatic cancer. Plaintiff attorneys generally look for:

  • Documented, repeated exposure — occupational use (landscapers, groundskeepers, farmworkers, nursery employees) generally supports a stronger claim than occasional home use, though home and garden use is also represented in the litigation.
  • A confirmed non-Hodgkin lymphoma diagnosis — including common subtypes such as diffuse large B-cell lymphoma, follicular lymphoma, and chronic lymphocytic leukemia/small lymphocytic lymphoma.
  • A plausible exposure-to-diagnosis timeline — attorneys and experts typically look for meaningful exposure occurring years before diagnosis, consistent with the latency period for NHL.

Purchase receipts, employer pesticide-application logs, or a personal history of buying and using Roundup products can all help document exposure if your case is not already part of the settlement class described below.

Current MDL Status: Bellwether Verdicts and the Supreme Court Ruling

Federal Roundup cases are consolidated as In re: Roundup Products Liability Litigation, MDL No. 2741, in the U.S. District Court for the Northern District of California. Early bellwether trials produced large plaintiff verdicts — most notably a 2018 California state-court verdict in favor of groundskeeper Dewayne Johnson, later reduced on appeal but still one of the largest product-liability awards in U.S. history — which helped drive the scale of the litigation that followed.

As of July 2026, roughly 3,920 cases remain open in the federal MDL. The litigation reached a major turning point in June 2026, when the U.S. Supreme Court ruled in Monsanto's favor on federal preemption, holding that Bayer's compliance with EPA-approved labeling can preempt state-law failure-to-warn claims in at least some circumstances. Bayer is now citing that ruling to push for dismissal of many of the remaining MDL cases — so the practical effect on any individual, not-yet-settled claim depends heavily on your specific state and case posture. This is exactly the kind of fast-moving detail an attorney needs to evaluate for your situation; it is not something a general guide can resolve for you.

The $7.25 Billion Proposed Settlement

In February 2026, Bayer announced a proposed $7.25 billion settlement intended to resolve current Roundup lawsuits alleging non-Hodgkin lymphoma, as well as future claims. The settlement received preliminary court approval in March 2026, and a final fairness hearing is scheduled for August 19, 2026.

Under the proposed terms, individual payouts are expected to range from roughly $6,000 to $165,000 depending on case-specific factors such as diagnosis severity, documented exposure, and age. The settlement is not yet final. Some plaintiffs' law firms have formally objected, arguing the deal undervalues claims, and Bayer's post-Supreme-Court push to dismiss remaining MDL cases adds further uncertainty about how the settlement and the Court's ruling interact for people who have not yet resolved their case.

Because this settlement's status can change quickly between the date this page was last reviewed and when you read it, always confirm the current status — including whether the August 19, 2026 hearing has occurred and what it decided — with a plaintiff attorney before assuming any specific payout applies to you.

Mass Tort vs. Class Action

Roundup claims are litigated as mass torts, not a single class action — each plaintiff's case and damages are evaluated individually, even within a global settlement like the one described above. That structure is why payout ranges vary so widely: a plaintiff with a severe, well-documented diagnosis and long exposure history can recover far more than the low end of the range. See our full mass torts hub and our plain-language guide to what is a mass tort for how this compares to a traditional class action.

How to Start a Roundup Claim

Step 1: Confirm Your Diagnosis

A confirmed non-Hodgkin lymphoma diagnosis from your treating physician or oncologist is the foundation of any claim. Gather pathology reports, oncology notes, and treatment records.

Step 2: Document Your Exposure History

Reconstruct when, where, and how often you used or were exposed to Roundup — employment records, purchase history, and any pesticide-application logs all help.

Step 3: Check Your Eligibility and Speak with an Attorney

Use our free eligibility check tool for a preliminary read on whether your situation matches the criteria attorneys are currently evaluating, then speak with a mass tort attorney about where your case stands given the pending settlement and the Supreme Court's June 2026 ruling. Most Roundup attorneys work on contingency — no upfront cost, and a fee only if your case recovers.

Statute of Limitations

Every Roundup claim is subject to a state statute of limitations — typically two to three years from your diagnosis date or from when you reasonably should have connected your illness to glyphosate exposure, depending on your state's discovery rule. Given the Supreme Court's June 2026 preemption ruling and the pending settlement approval hearing, waiting to evaluate your claim carries real risk on top of the ordinary filing deadline. Speak with an attorney promptly to understand how these developments affect your specific timeline.

Frequently Asked Questions

Is the Roundup lawsuit settlement final?

Not yet, as of this page's last update. Bayer's proposed $7.25 billion settlement received preliminary court approval in March 2026, but the final fairness hearing was scheduled for August 19, 2026, and some plaintiffs have objected to the terms. Confirm the current status with an attorney before assuming a specific payout applies to your case.

How does the Supreme Court's 2026 ruling affect my Roundup claim?

In June 2026, the Supreme Court ruled in Monsanto's favor on federal preemption for failure-to-warn claims, and Bayer is using that ruling to seek dismissal of remaining MDL cases. Whether this affects your specific claim depends on your state, your case's procedural posture, and whether you are already part of the proposed settlement — this is a fast-changing legal question that only an attorney reviewing your specific case can answer.

How much is a Roundup lawsuit worth?

Under the proposed settlement, individual payments are expected to range from roughly $6,000 to $165,000, depending on diagnosis severity, documented exposure, and other case-specific factors. Cases litigated individually outside the settlement, where still viable, have in the past produced significantly larger bellwether verdicts, though those are not typical outcomes and are now complicated by the Supreme Court's preemption ruling.

Do I need a lawyer to file a Roundup claim?

You are not legally required to hire an attorney, but nearly all Roundup attorneys work on contingency — no upfront cost, and a fee only if you recover. Given how actively this litigation is changing, an attorney is especially important right now to tell you whether your claim is part of the pending settlement, still viable after the Supreme Court's ruling, or subject to dismissal.

What if I only used Roundup around my home, not professionally?

Home and garden use is represented in the litigation alongside occupational exposure, though claims with longer, more frequent, and better-documented exposure — such as occupational spraying — have generally been viewed as stronger. An eligibility check or attorney consultation can tell you how your specific exposure history is likely to be evaluated.

Find Out If You Have a Roundup Claim

If you were regularly exposed to Roundup and were later diagnosed with non-Hodgkin lymphoma, you may have a claim — but the litigation is moving quickly following the 2026 Supreme Court ruling and the pending settlement approval hearing.

Use our free eligibility check to see if your situation matches what plaintiff attorneys are currently accepting. There is no cost, no obligation, and no attorney fees unless you win.

For broader context, see our overview of mass torts and our plain-language guide to what is a mass tort.

Not sure where you stand?

Check your eligibility in under 2 minutes — free, private, and no commitment required.

Latest related briefings